Loading…
5 companies · GEL, thousands · columns ordered by revenue
GEL, thousands · money Σ · ratios from summed bases · growth on the pooled series
| Metric | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 3,380 | 7,238 | 20,346 | 32,458 | 14,159 | 9,519 | 990 |
| EBITDA | 1,534 | 3,687 | 4,689 | 16,808 | 5,265 | 167 | -123 |
| Net profit | 1,301 | 3,368 | 4,639 | 16,195 | 5,375 | 2,736 | 107 |
| Total assets | 3,451 | 11,564 | 15,773 | 34,268 | 30,188 | 31,427 | 24,586 |
| n (companies reporting) | 2 | 4 | 5 | 5 | 4 | 4 | 2 |
GEL, thousands
| Company | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|---|---|---|---|
| Helios Pharma | 3,380 | 4,277 | 4,702 | 4,865 | 8,432 | 3,464 | 645 |
| Weekend | — | 0 | 11,143 | 19,223 | 0 | 5,128 | 345 |
| New Medi | — | — | 0 | 3,024 | 2,305 | 193 | — |
| Medi-Hels | — | 0 | 2,466 | 4,379 | 3,422 | 734 | — |
| Deilait Kompani | 0 | 2,961 | 2,035 | 967 | — | — | — |
Rows are the raw pool — every peer, including any excluded from the sums above, so the de-duplication stays auditable. Tinted cells are the excluded company-years.
Peer coverage varies by year — FY2018–FY2020, FY2022–FY2024 pool fewer than the 5 picked companies (see the n row). A year is never dropped because one peer is missing.
Pooled figures sum every peer in the set. Known parent/subsidiary groups that file separately are de-duplicated; groups not yet curated may still be counted more than once.